Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2215 of 5804
-
New injection aims to ease Post-Surgery pain without opioids
Symptom relief Recruiting nowThis is a multi-center, randomized, double-blind, double-dummy, placebo/active-controlled study. 200 subjects undergoing abdominal surgery under general anesthesia are planned to be enrolled and randomized into the HSK55718 group, morphine group, and placebo group.
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
New drug trial aims to ease fragile x symptoms in men
Symptom relief Recruiting nowThe purpose of this Phase IIa study is to evaluate the safety, tolerability, and effectiveness of CTH120 in adult males with Fragile X syndrome.
Phase: PHASE2 • Sponsor: Connecta Therapeutics, S.L. • Aim: Symptom relief
Last updated Jul 19, 2026 00:00 UTC
-
Engineered immune cells aim to repair damaged hearts
Disease control Recruiting nowThis study aims to evaluate the safety and efficacy of fibroblast activation protein (FAP)-targeted autologous immunosuppressive chimeric antigen receptor dendritic cell (iCDC) therapy in patients with ischemic cardiomyopathy, and to explore its potential as a novel therapeutic s…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New drug IBI115 enters human testing for tough lung cancer
Disease control Recruiting nowThis study is a multi-regional, open-label phase I study to evaluate the Safety, Tolerability, and Efficacy of IBI115 as Monotherapy and in Combination Therapy in Participants with Advanced Small Cell Lung Cancer
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New Antibody-Drug conjugate IM-1617 enters human trials for advanced cancers
Disease control Recruiting nowThis study will test the safety and effectiveness of a drug called IM-1617 in participants with solid tumors. Participants will have solid tumor cancer that has spread through the body (metastatic) or cannot be removed with surgery (unresectable). This study will have two parts.…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New digital heart rehab could help patients recover at home
Disease control Recruiting nowThe overall aim of eCardiacRehab trial is to meet rehabilitation needs of patients with coronary artery disease (CAD) regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and …
Phase: NA • Sponsor: Haukeland University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
ER alert system aims to boost addiction care for opioid patients
Disease control Not yet recruitingThis study is stage 2, round 2 of a larger study which refines and optimizes the EMBED clinical decision support (CDS); see NCT03658642 to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use d…
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Light therapy may soothe radiation burns in breast cancer patients
Symptom relief Recruiting nowThis assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast cancer undergoing hypofractionated whole-breast ra…
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Could a soy supplement help your liver? new trial investigates
Disease control Not yet recruitingThis clinical trial aims to learn whether daidzein can improve liver tissue changes in adults with metabolic dysfunction-associated steatotic liver disease, also called MASLD. MASLD is a liver condition linked to extra fat in the liver and metabolic problems such as obesity, diab…
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Acupuncture needles aim to tame asthma and anxiety
Symptom relief Not yet recruitingAsthma is a common chronic respiratory disease with a low clinical control rate, highlighting the need for novel therapeutic strategies. Recurrent asthma attacks emotional symptoms, such as anxiety and depression, etc. On the contrary, symptoms such as anxiety and depression wors…
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New suction device may improve kidney stone removal
Disease control Recruiting nowThe goal of this clinical trial is to compare Steerable Ureteroscopic Renal Evacuation (SURE) using the CVAC System and standard ureteroscopy (URS) with laser lithotripsy for the treatment of urolithiasis. This is a prospective, randomized (1:1), multi-center study.
Phase: NA • Sponsor: Calyxo, Inc. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New pill aims to shrink spleen and ease symptoms in hard-to-treat bone marrow cancer
Disease control Recruiting nowThis is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in participants with myelofibrosis (MF).The dose escalation portion utilizes a standard 3+3 design to evaluate two dose levels with an additional dose de-escalation portion to…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New brain zapping technique could ease Parkinson's symptoms without surgery
Symptom relief Recruiting nowTranscranial temporal interference stimulation (tTIS) is a non-invasive deep brain stimulation method. This study aims to comprehensively explore the efficacy and safety of bilateral subthalamic nucleus (STN) tTIS on motor and non-motor symptoms in patients with Parkinson's disea…
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Can microneedling and UV light restore skin color in vitiligo?
Disease control Not yet recruitingThis study is a randomized controlled trial comparing microneedling with topical minoxidil 5% versus microneedling with minoxidil combined with NB-UVB phototherapy in stable vitiligo. It aims to evaluate both clinical and histopathological outcomes in 30 patients with non-segmen…
Phase: PHASE2 • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New program aims to break Teens' social media addiction
Symptom relief Not yet recruitingThis study evaluates the effectiveness of the 4-STEP Training Program in reducing social media addiction and improving psychological well-being among adolescents. Increasing use of social media has been linked with anxiety, depression, stress, sleep problems, low self-esteem, and…
Phase: NA • Sponsor: Government College University Faisalabad • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Rhythm and recovery: music may boost therapy for kids with CP
Symptom relief Not yet recruiting* To investigate the effect of music therapy as an additional intervention with physical therapy on concentration in children with spastic CP. * To investigate the effect of music therapy as an additional intervention with physical therapy on gait parameters for the children with…
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
Magnetic pulses to the brain may help you sleep better
Symptom relief Not yet recruitingChronic insomnia disorder is a common condition in which people have ongoing difficulty falling asleep, staying asleep, or waking too early. It affects about 10-12% of adults and can lead to daytime problems, stress, and other health issues. Current treatments include talk therap…
Phase: NA • Sponsor: San Francisco Neurology and Sleep Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Could a common gout pill boost antidepressants?
Symptom relief Not yet recruitingMajor depressive disorder (MDD) is one of the most common psychiatric disorders with serious socioeconomic consequences on daily life and health care costs. Despite the advent of newer antidepressants that target monoamine pathways, nearly 50% of patients have no response to firs…
Phase: PHASE2, PHASE3 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Weighted blankets put to the test for ADHD Kids' sleepless nights
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate if a commercially available (retail-grade) weighted blanket can improve sleep in children with Attention Deficit Hyperactivity Disorder (ADHD) and sleep disturbances. 100 children will be enrolled in the study. The location of the…
Phase: NA • Sponsor: University Hospital Bispebjerg and Frederiksberg • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Virtual reality meets brain zaps: new hope for stroke recovery?
Symptom relief Recruiting nowThe aim of this randomized controlled trial is to determine the effects of Augmented Reality (AR)-based balance training on improving balance and postural control in chronic stroke survivors and whether the addition of transcranial Direct Current Stimulation (tDCS) to AR training…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC